License Raj Makes A Comeback
National Pharmaceutical Pricing Authority’s move to cap pricing of coronary stents would adversely affect well-to-do patients and medical tourism industry in India After the Delhi High court passed the order to slash the price of stents, National Pharmaceutical Pricing Authority (NPPA), a government regulatory agency issued a order on 13th Feb, 2017. This order came as …